IL6 and fungal infectious disease: This result is coincident with Falcone et al.'s study where the findings suggested that patients receiving immunosuppressants (like interleukin-6 inhibitors or Janus kinase inhibitors) during their hospital stay may face an increased risk of acquiring bacterial and fungal infections (13).